Microfluidic chip-based co-culture system for modeling human joint inflammation in osteoarthritis research
Frontiers in Pharmacology · 09.04.2025 · 16
DOI: 10.3389/fphar.2025.1579228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.04.2025. Verfasst von Hosein Mirazi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanoscience and Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD, United States. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Here we present a microfluidic model that allows for co-culture of human osteoblasts, chondrocytes, fibroblasts, and macrophages of both quiescent (M0) and pro-inflammatory (M1) phenotypes, maintaining initial viability of each cell type at 24 h of co-culture. We established healthy (M0-based) and diseased (M1-based) joint models within this system. An established disease model based on supplementation of IFN-γ and lipopolysaccharide in cell culture media was used to induce an M1 phenotype in macrophages to recapitulate inflammatory conditions found in Osteoarthritis. Cell viability was assessed using NucBlue™ Live and NucGreen™ Dead fluorescent stains, with mean viability of 83.9% ± 14% and 83.3% ± 12% for healthy and diseased models, respectively, compared with 93.3% ± 4% for cell in standard monoculture conditions. Cytotoxicity was assessed via a lactate dehydrogenase (LDH) assay and showed no measurable increase in lactate dehydrogenase release into the culture medium under co-culture conditions, indicating that neither model promotes a loss of cell membrane integrity due to cytotoxic effects. Cellular metabolic activity was assessed using a PrestoBlue™ assay and indicated increased cellular metabolic activity in co-culture, with levels 5.9 ± 3.2 times mean monolayer cell metabolic activity levels in the healthy joint model and 5.3 ± 3.4 times mean monolayer levels in the diseased model. Overall, these findings indicate that the multi-tissue nature of in vivo human joint conditions can be recapitulated by our microfluidic co-culture system at 24 h and thus this model serves as a promising tool for studying the pathophysiology of rheumatic diseases and testing potential therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nanoscience and Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD, United States.
- Portland Laboratory for Biotechnology and Health Sciences, University of New England, Portland, ME, United States.
- Department of Biomedical Sciences, University of New England, Biddeford, ME, United States.
Förderung
- National Science Foundation
Zitieren
APA
Mirazi, H., & Wood, S. T. (2025). Microfluidic chip-based co-culture system for modeling human joint inflammation in osteoarthritis research. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1579228
Vancouver
Mirazi H, Wood ST. Microfluidic chip-based co-culture system for modeling human joint inflammation in osteoarthritis research. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1579228
BibTeX
@article{Mirazi2025,
author = {Mirazi, Hosein and Wood, Scott T},
title = {Microfluidic chip-based co-culture system for modeling human joint inflammation in osteoarthritis research},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1579228}
}
EUVIMED